ArticleFrontiers in oncology2024
Survival outcomes and contributing factors in oral squamous cell carcinoma patients in Khuzestan province, southwest of Iran.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lip and oral cavity cancer in Iran from 1990 to 2019 based on the global burden of disease study.Scientific reports · 2025Article
- Article
- Automated detection of basement-membrane breaches in oral squamous cell carcinoma : A comparative study of convolutional neural network architectures.Journal of oral biology and craniofacial researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral squamous cell carcinoma (OSCC) is the most frequent oral cancer worldwide. Despite advances in OSCC treatment, the mortality rate has not decreased in recent years. Therefore, the aim of this investigation was to assess the survival rate as a factor reflecting the quality aspects of care and background parameters that influence survival in patients with OSCC. Methods: This is a retrospective analysis of 165 patients with OSCC who were registered in the Khuzestan cancer registry system in 2014 to 2018. The data were collected in two parts: demographic information and survival information. Demographic and background variables include age, gender, marital status, ethnicity, employment status, insurance status, and educational status. Survival information was also collected through phone calls to patients or their families. The survival rate of the patients was analyzed using the log-rank test and the influencing factors were analyzed with the Cox regression test. Results: In this study, 165 patients, 43 women (26.1%) and 122 men (73.9%), with OSCC were included. The follow-up period of the patients was 5 years (2014-2019), during which 74 patients died. One, three, and five-year survival rates were 93.34%, 71.51%, and 44.84%, respectively. The results showed that age (χ Conclusion: Since all background factors were not associated with survival rate, efforts should continue to identify effective factors and investigate the relationship between survival and pathological factors such as recurrence status, distant metastasis, type of treatment, and involved organs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.